Alternatives to Forteo If You Can't Fill Your Prescription

Forteo (teriparatide) is one of the most powerful tools available for treating severe osteoporosis. But what happens when you can't fill your prescription? Whether it's an insurance denial, a pharmacy access issue, or cost concerns, patients sometimes need an alternative.

The good news: there are several FDA-approved osteoporosis medications that your doctor may consider as alternatives. Here's a clear breakdown of your options in 2026.

What Makes Forteo Unique?

Before comparing alternatives, it helps to understand what Forteo actually does. Unlike most osteoporosis drugs that work by preventing bone breakdown (antiresorptive agents), Forteo is an osteoanabolic agent—meaning it actively stimulates the formation of new bone. It does this by mimicking intermittent parathyroid hormone (PTH) signaling, which activates osteoblasts (bone-building cells) more than osteoclasts (bone-resorbing cells).

This makes Forteo particularly valuable for patients with severe osteoporosis, multiple vertebral fractures, or those who haven't responded well to antiresorptive therapies. Any alternative will either work differently or offer different trade-offs in terms of efficacy, administration, and side effects.

Alternative #1: Abaloparatide (Tymlos) — Closest Substitute

Abaloparatide (brand name: Tymlos) is the closest functional alternative to Forteo. Like Forteo, it is a daily subcutaneous injection that builds new bone. It's a parathyroid hormone-related peptide (PTHrP) analog rather than a PTH analog, but it works through a very similar mechanism.

Key differences from Forteo:

Room temperature storage: Tymlos pens can be kept at room temperature for up to 30 days after first use, unlike Forteo which must stay refrigerated. This makes Tymlos more convenient for travel.

Brand only: Tymlos is currently only available as a brand-name drug. Generic teriparatide (for Forteo) has been available since late 2023.

Fracture reduction data: Clinical studies suggest Tymlos may be slightly better at reducing major osteoporotic fractures, while Forteo has an edge in reducing painful vertebral fractures specifically.

If your doctor prescribed Forteo for glucocorticoid-induced osteoporosis specifically, note that Tymlos does not have an FDA-approved indication for this use—Forteo does.

Alternative #2: Romosozumab (Evenity) — Dual-Action Bone Builder

Romosozumab (brand name: Evenity) is a newer anabolic option with a unique dual mechanism: it both stimulates bone formation AND inhibits bone resorption simultaneously. It does this by blocking sclerostin, a protein that normally suppresses bone formation.

Key differences from Forteo:

Monthly injection: Evenity is given as two subcutaneous injections once a month by a healthcare provider for 12 months, then followed by an antiresorptive therapy.

Cardiovascular warning: Evenity carries a boxed warning for increased risk of heart attack and stroke. It's contraindicated in patients with a history of MI or stroke within the past year.

Bone density gains: Head-to-head studies have shown Evenity can produce greater bone density gains over 12 months than Forteo—up to 11% spine BMD increase vs. 7% for teriparatide.

Alternative #3: Denosumab (Prolia) — Antiresorptive Injection

Denosumab (brand name: Prolia) is an antiresorptive agent, not an anabolic one—meaning it prevents bone loss rather than building new bone. It works by blocking RANKL, a protein that activates bone-resorbing osteoclasts. It is given as an injection every 6 months by a healthcare provider.

An important consideration: Prolia must not be abruptly discontinued. Stopping denosumab without transitioning to another therapy creates a significant rebound fracture risk. Patients must commit to ongoing therapy.

Alternative #4: Bisphosphonates — Oral First-Line Options

Bisphosphonates like alendronate (Fosamax), risedronate (Actonel), and zoledronic acid (Reclast IV infusion) are the most commonly prescribed first-line osteoporosis treatments. They work by slowing bone resorption. Oral generics like alendronate are widely available and very affordable.

Important: Most insurance plans require patients to try and fail bisphosphonates before they will approve Forteo or other anabolic therapies. If you're already on a bisphosphonate and not responding adequately, that documented failure may be exactly what's needed to get Forteo approved.

How to Choose the Right Alternative

Your doctor will consider the following factors when recommending an alternative:

Fracture history and bone density (T-score)

Whether the osteoporosis is glucocorticoid-induced (Forteo is specifically approved for this)

Cardiovascular history (rules out Evenity if recent MI or stroke)

Insurance formulary (which drugs are preferred or require less PA work)

Patient preference for injection frequency and administration setting

The Bottom Line

If you can't access Forteo right now, you have real options. Talk to your doctor about which alternative fits your medical situation and insurance coverage. And if cost or availability is the primary issue, first try using medfinder and exploring the Forteo savings card program before switching medications—you may be able to get access after all. See our guide on how to find Forteo in stock near you for step-by-step help.